Additionally, the timing of basal insulin administration in patients on basal-bolus therapy was not associated with nocturnal hypoglycemia or PHNH, regardless of whether next- or earlier-generation formulations were used (data not shown). This evidence concerns the gene INS and Hypoglycemia.